Combinations Key For Amgen’s Lumakras, But PD-1/L1 Data Held Until August

Combo Importance Increases With Sales Growth Slowing

 
• By Mandy Jackson
  
Lungs icon, anatomy, health care concept
Amgen's first Lumakras combination therapy results in lung cancer will be presented at WCLC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D